PCDH10 is required for the tumorigenicity of glioblastoma cells.
暂无分享,去创建一个
Tomoatsu Hayashi | T. Akiyama | T. Todo | A. Mukasa | Kenta Terai | Y. Ino | M. Nakada | Y. Morishita | T. Furuta | H. Sabit | S. Hirano | M. Nakai | Y. Nishimura | Shunsaku Takayanagi | R. Ohtani | Nobuhito Saito | Ryo Koyama-Nasu | Kenzui Taniue | Kanae Echizen
[1] H. Aburatani,et al. The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells , 2013, Oncogene.
[2] Yongliang Zhu,et al. Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer , 2013, Journal of Cancer Research and Clinical Oncology.
[3] Zheng-Kai He,et al. Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer , 2013, The Journal of international medical research.
[4] M. Takeichi,et al. Cadherins in brain morphogenesis and wiring. , 2012, Physiological reviews.
[5] L. Parada,et al. Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells , 2012, Cell.
[6] R. Russell,et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. , 2009, Cell stem cell.
[7] Qian Tao,et al. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. , 2009, Gastroenterology.
[8] M. Takeichi,et al. Contact-dependent promotion of cell migration by the OL-protocadherin–Nap1 interaction , 2008, The Journal of cell biology.
[9] M. Takeichi,et al. OL-protocadherin is essential for growth of striatal axons and thalamocortical projections , 2007, Nature Neuroscience.
[10] T. Marafioti,et al. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies , 2007, British journal of haematology.
[11] M. Berens,et al. Molecular targets of glioma invasion , 2007, Cellular and Molecular Life Sciences.
[12] Yuri Kotliarov,et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.
[13] T. Putti,et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation , 2006, Oncogene.
[14] T. Sugimura,et al. Identification of 20 genes aberrantly methylated in human breast cancers , 2005, International journal of cancer.
[15] T. Maniatis,et al. A Striking Organization of a Large Family of Human Neural Cadherin-like Cell Adhesion Genes , 1999, Cell.
[16] S. Hirano,et al. Expression of a Novel Protocadherin, OL-Protocadherin, in a Subset of Functional Systems of the Developing Mouse Brain , 1999, The Journal of Neuroscience.